An outpatient psychiatric evaluation is requested for a 31-year-old female software developer who reports feeling 'empty and constantly on edge.' The patient states that she has struggled with intense, unstable interpersonal relationships since late adolescence, often fluctuating between idealized infatuation and extreme devaluation of her partners. She exhibits the defense mechanism of splitting, explicitly categorizing her current treatment team as 'the only ones who actually care' and her previous providers as 'malicious and incompetent.' Her history is notable for recurrent non-suicidal self-injury via superficial skin cutting following perceived abandonments. Over the past week, following a severe conflict with her roommate, she has experienced transient, stress-induced auditory hallucinations of a voice whispering her name. Furthermore, she describes short-lived periods of profound depressive symptoms interspersed with significant irritability and impulsive spending. She is currently prescribed paroxetine for anxiety. During the interview, she mentions having found a bottle of phenelzine in her mother's medicine cabinet and asks if she should start taking it alongside her paroxetine for 'extra help.' She also expresses intense anger toward her roommate, vaguely stating she would 'love to see her get hit by a bus,' but when assessed further, she denies any actual plan or intent to harm her. Which of the following is the most appropriate management strategy for this patient?
- ADiagnose schizophrenia due to the presence of auditory hallucinations and initiate a second-generation antipsychotic
- BWarn the patient's roommate of a potential threat, thereby breaching confidentiality to ensure third-party safety
- Acknowledge her distress, delineate strict therapeutic boundaries, advise against the monoamine oxidase inhibitor, and refer the patient for dialectical behavior therapyCevap
- DEndorse the addition of the monoamine oxidase inhibitor to her regimen to address her chronic feelings of emptiness
- ETreat for suspected bipolar depression by maximizing the dosage of her current selective serotonin reuptake inhibitor